4//SEC Filing
K-V Pharmaceutical Co 4
Accession 0001240547-13-000002
CIK 0000057055operating
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 3:43 PM ET
Size
8.5 KB
Accession
0001240547-13-000002
Insider Transaction Report
Form 4
K-V Pharmaceutical CoKVA/KVB
MCHUGH THOMAS S
Chief Financial Officer
Transactions
- Award
Option to Purchase
2013-09-27+40,327→ 40,327 totalExercise: $20.00Exp: 2023-09-27→ Common Stock (40,327 underlying) - Award
Restricted Stock Units
2013-09-16+86,806→ 86,806 total→ Common Stock (86,806 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the company's common stock.
- [F2]The restricted stock units vest in the following installments: one-sixth on September 16, 2013, one-sixth on September 16, 2014, one-third on September 16, 2015 and one-third on September 16, 2016, subject to Mr. McHugh's continued employment with the company through the applicable vesting date. The unvested portion of these restricted stock units will vest upon a change in control of the company. All vested restricted stock units will be settled in shares of common stock upon the earliest to occur following the applicable vesting date: Mr. McHugh's separation from service with the company; a change of control of the company; or March 31, 2018.
- [F3]The option vests in the following installments: one-sixth on September 27, 2013, one-sixth on September 27, 2014, one-third on September 27, 2015 and one-third on September 27, 2016, but does not become exercisable until the earliest of January 1, 2019, a change in control of the company or termination without cause of Mr. McHugh's employment relationship with the company.
Documents
Issuer
K-V Pharmaceutical Co
CIK 0000057055
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000057055
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 3:43 PM ET
- Size
- 8.5 KB